Home/Filings/4/0001722482-23-000075
4//SEC Filing

Brophy Gerard 4

Accession 0001722482-23-000075

CIK 0001722482other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 8:10 PM ET

Size

10.0 KB

Accession

0001722482-23-000075

Insider Transaction Report

Form 4
Period: 2023-02-23
Brophy Gerard
EVP, Biopharma Production
Transactions
  • Tax Payment

    Common Stock

    2023-02-25$24.62/sh2,040$50,225115,688 total
  • Award

    Stock Options (Right to Buy)

    2023-02-24+49,21549,215 total
    Exercise: $24.62Exp: 2033-02-24Common Stock (49,215 underlying)
  • Tax Payment

    Common Stock

    2023-02-23$24.59/sh1,893$46,54997,420 total
  • Award

    Common Stock

    2023-02-24+20,308117,728 total
Footnotes (3)
  • [F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
  • [F2]Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024.
  • [F3]Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024.

Issuer

Avantor, Inc.

CIK 0001722482

Entity typeother

Related Parties

1
  • filerCIK 0001776107

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:10 PM ET
Size
10.0 KB